S. Skouby

发表

Effect of dosage of 17ß-estradiol on uterine growth in Turner syndrome - a randomized controlled clinical pilot trial.

C. Gravholt, E. Fallentin, L. Cleemann, 2020, The Journal of clinical endocrinology and metabolism.

Oral contraceptives in diabetic women: metabolic effects of four compounds with different estrogen/progestogen profiles.

P. Bennet, S. Skouby, C. Kühl, 1986, Fertility and sterility.

Assessment of endothelial function during oral contraception in women with insulin-dependent diabetes mellitus.

J. Jespersen, S. Skouby, K. Petersen, 1994, Metabolism: clinical and experimental.

Tibolone histology of the endometrium and breast endpoints study: design of the trial and endometrial histology at baseline in postmenopausal women.

A. Ferenczy, W. den Hollander, D. Archer, 2007, Fertility and sterility.

Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations.

J. Jespersen, J. Gram, S. Skouby, 2002, American journal of obstetrics and gynecology.

A distinctive epigenetic ageing profile in human granulosa cells.

G. Kelsey, A. Cardona, J. R. Perry, 2020, Human reproduction.

Endometrial effects of tibolone.

A. Ferenczy, W. den Hollander, D. Archer, 2007, The Journal of clinical endocrinology and metabolism.

Mechanism of action of oral contraceptives on carbohydrate metabolism at the cellular level.

S. Skouby, C. Kühl, Petersen Kr, 1990 .

Effect of Oral Contraceptives on Carbohydrate Metabolism in Healthy Women

S. Skouby, 1988 .

Efectos metabólicos de los anticonceptivos orales

J. Jespersen, S. Skouby, K. P. Petersen, 1993 .

Impact of Menstrual Function on Hormonal Response to Repeated Bouts of Intense Exercise

C. Ritz, Å. Tornberg, A. Sjödin, 2019, Front. Physiol..

Atrial natriuretic peptide, copeptin and adrenomedullin levels in polycystic ovary syndrome: a case-control study

J. Faber, S. Skouby, C. Kistorp, 2017, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Endogenous thrombin potential in polycystic ovary syndrome: the association to body mass index, insulin resistance, and inflammation

J. Faber, S. Skouby, M. L. Wissing, 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Contraceptive use and behavior in the 21st century: a comprehensive study across five European countries

S. Skouby, Sven O. Skouby, 2004, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS

J. Faber, S. Skouby, C. Kistorp, 2017, Endocrine connections.

Comparative Trial of the Effects on Glucose Tolerance and Lipoprotein Metabolism of two New Oral Contraceptives Containing Gestoden and Desogestrel

S. Skouby, K. Petersen, B. Svenstrup, 1988, Acta obstetricia et gynecologica Scandinavica.

Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women

J. Heikkinen, L. Mattsson, M. Rees, 2007, Menopause international.

Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential

J. Faber, S. Skouby, C. Kistorp, 2017, Endocrine connections.

Preparation of the endometrium and timing of blastocyst transfer in modified natural cycle frozen-thawed embryo transfers (mNC-FET): a study protocol for a randomised controlled multicentre trial

A. Pinborg, U. Knudsen, M. R. Petersen, 2019, BMJ Open.

Sex hormone‐binding globulin as a marker for the thrombotic risk of hormonal contraceptives: a rebuttal

J. Jespersen, C. Kluft, J. Burggraaf, 2013, Journal of Thrombosis and Haemostasis.

Estrogen receptor 1 haplotype does not regulate oral contraceptive-induced changes in haemostasis and inflammation risk factors for venous and arterial thrombosis.

J. Jespersen, C. Kluft, M. D. de Maat, 2006, Human reproduction.

The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study.

P. Crosignani, J. Jespersen, D. Mishell, 2003, Contraception.

Oral contraceptives and venous thrombosis: end of the debate?

S. Skouby, 1998, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

HT: Pharmacology Tailored to Women’s Health

S. Skouby, 2019, ISGE Series.

Hormonal contraception in obesity, the metabolic syndrome, and diabetes

S. Skouby, 2010, Annals of the New York Academy of Sciences.

Progestins in HRT: sufferance or desire?

S. Skouby, J. Jespersen, 2009, Maturitas.

A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.

C. Gerlinger, J. Endrikat, B. Düsterberg, 2005, Contraception.

Effects of conjugated estrogens/bazedoxifene on lipid and coagulation variables: a randomized placebo- and active-controlled trial

B. Komm, K. Pan, S. Mirkin, 2015, Menopause.

A comparative study of the effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on blood coagulability.

J. Jespersen, L. Nilas, S. Skouby, 2007, Human reproduction.

Does adjuvant letrozole reduce uterine peristalsis prior to fresh embryo transfer?

S. Skouby, N. Macklon, A. L. Englund, 2022, Human reproduction open.

Lipidomic profiles, lipid trajectories and clinical biomarkers in female elite endurance athletes

S. Brunak, Å. Tornberg, L. Ahonen, 2020, Scientific Reports.

Ovulation inhibition by estetrol in an in vivo model.

H. C. Coelingh Bennink, S. Skouby, P. Bouchard, 2008, Contraception.

Ovulation inhibition by estetrol in an in vivo model

H. C. Coelingh Bennink, S. Skouby, H. Bennink, 2008, Climacteric : the journal of the International Menopause Society.

Estrogen replacement therapy in combination with continuous intrauterine progestin administration reduces the amount of circulating oxidized LDL in postmenopausal women: dependence on the dose of progestin

T. Vasankari, T. Hakonen, I. Rauramo, 2004, Annals of medicine.

The metabolic issues of hormone replacement therapy

S. Skouby, 2003 .

Consequenses for HRT following the HERS II and WHI reports: The primum non nocere is important, but translation into quo vadis is even more essential

S. Skouby, 2002, Acta obstetricia et gynecologica Scandinavica.

Reduced Neuromuscular Performance in Amenorrheic Elite Endurance Athletes

Å. Tornberg, A. Johansson, A. Sjödin, 2017, Medicine and science in sports and exercise.

Low‐energy density and high fiber intake are dietary concerns in female endurance athletes

Å. Tornberg, A. Sjödin, J. Sundgot-Borgen, 2016, Scandinavian journal of medicine & science in sports.

Quantification of visceral adipose tissue in polycystic ovary syndrome: dual-energy X-ray absorptiometry versus magnetic resonance imaging

J. Faber, S. Skouby, C. Kistorp, 2018, Acta radiologica.

Oestrogen-free oral contraception with a 4 micrograms drospirenone-only pill: new data and a review of the literature

D. Apter, S. Weyers, N. Ács, 2020 .

The effect of continuous combined conjugated equine estrogen plus medroxyprogesterone acetate and tibolone on cardiovascular metabolic risk factors

J. Jespersen, L. Nilas, J. Gram, 2008, Climacteric : the journal of the International Menopause Society.

Hormone replacement therapy and hypercoagulability. Results from the Prospective Collaborative Danish Climacteric Study

J. Jespersen, S. Skouby, J. Sidelmann, 2003, BJOG : an international journal of obstetrics and gynaecology.

Polycystic ovary syndrome and low-grade inflammation with special reference to YKL-40

J. Faber, S. Skouby, M. L. Wissing, 2014, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Effects of contraceptive steroids on cardiovascular risk factors in women with insulin-dependent diabetes mellitus.

J. Jespersen, S. Skouby, L. Mølsted‐Pedersen, 1994, American journal of obstetrics and gynecology.

Preconception Counseling and Contraception After Gestational Diabetes

P. Damm, S. Skouby, L. Mølsted‐Pedersen, 1991, Diabetes.

Identification of a unique epigenetic profile in women with diminished ovarian reserve.

G. Kelsey, A. Cardona, M. Bungum, 2020, Fertility and sterility.

Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor.

J. Jespersen, E. Bladbjerg, S. Skouby, 2002, Human reproduction.

Menopausal Hormone Therapy (MHT) and Venous Thrombosis

S. Skouby, J. Sidelmann, 2020 .

The EMAS 2006/2007 update on clinical recommendations on postmenopausal hormone therapy.

D. Barlow, S. Skouby, S. Rozenberg, 2007, Maturitas.

Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial

J. Holst, J. Frystyk, J. Faber, 2018, Diabetes, obesity & metabolism.

Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial.

J. Faber, S. Skouby, C. Kistorp, 2017, Reproductive biomedicine online.

Ovarian morphology in polycystic ovary syndrome: estimates from 2D and 3D ultrasound and magnetic resonance imaging and their correlation to anti-Müllerian hormone

J. Faber, S. Skouby, E. Chabanova, 2017, Acta radiologica.

The LIPT-Study: On Risk Markers of Vascular Thrombosis in Polycystic Ovary Syndrome. A Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Liraglutide

J. Faber, S. Skouby, C. Kistorp, 2015 .

Polycystic ovary syndrome: infertility, cardiovascular, metabolic and obstetrical risks, laboratory and clinical outcomes—The PICOLO Study

L. Nilas, S. Skouby, M. L. Wissing, 2012, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

A 1-year study to compare the hemostatic effects of oral contraceptive containing 20 microg of ethinylestradiol and 100 microg of levonorgestrel with 30 microg of ethinylestradiol and 100 microg of levonorgestrel.

C. Gerlinger, J. Endrikat, J. Jespersen, 2005, Contraception.

Original research article A 1-year study to compare the hemostatic effects of oral contraceptive containing 20 Ag of ethinylestradiol and 100 Ag of levonorgestrel with 30 Ag of ethinylestradiol and 100 Ag of levonorgestrel B

C. Gerlinger, J. Endrikat, J. Jespersen, 2005 .

Different response of the hemostatic system to oral contraception in diabetic and non-diabetic women

J. Jespersen, S. Skouby, J. Sidelmann, 1996 .

Balance of coagulation activity with fibrinolysis during use of oral contraceptives in women with insulin-dependent diabetes mellitus.

J. Jespersen, S. Skouby, K. Petersen, 1995, International journal of fertility and menopausal studies.

Within‐day energy deficiency and reproductive function in female endurance athletes

Å. Tornberg, A. Sjödin, J. Sundgot-Borgen, 2018, Scandinavian journal of medicine & science in sports.

Hormone therapy affects plasma measures of factor VII-activating protease in younger postmenopausal women

F. Vitzthum, J. Jespersen, S. Skouby, 2010, Climacteric.

Health in the menopause: advances in management

S. Skouby, 2004 .

Lack of difference among progestins on the anti-atherogenic effect of ethinyl estradiol: a rabbit study.

C. Christiansen, P. Alexandersen, P. Zandberg, 2003, Human Reproduction.

On the route to combined evidence from OC and HRT/ERT.

J. Jespersen, C. Kluft, G. Lowe, 2002, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

On the route to combined evidence from OC and HRT/ERT

S. Skouby, 2002 .

Increased concentration of circulating atrial natriuretic peptide during normal pregnancy.

G. Thamsborg, S. Skouby, T. Storm, 1988, European journal of obstetrics, gynecology, and reproductive biology.

Hormonal contraception in diabetic women: acceptability and influence on diabetes control and ovarian function of a nonalkylated estrogen/progestogen compound.

S. Skouby, C. Kühl, L. Mølsted‐Pedersen, 1985, Contraception.

Oral contraceptives: hormonal dose and effects on carbohydrate metabolism.

S. Skouby, 1988, Maturitas.

A randomised study comparing the effect on ovarian activity of a progestogen-only pill (POP) containing desogestrel and a new POP containing drospirenone in a 24/4 regimen

D. Heger-Mahn, S. Skouby, D. Drouin, 2015, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

The Impact of the Biological Variability or Assay Performance on AMH Measurements: A Prospective Cohort Study With AMH Tested on Three Analytical Assay-Platforms

A. Giwercman, N. Tørring, T. Klausen, 2018, Front. Endocrinol..

Estetrol (E4), the next generation hormone therapy (HT) for menopausal symptoms: phase 2b clinical trial results

J. Foidart, R. Lobo, U. Gaspard, 2019, Maturitas.

ESC expert statement on the effects on mood of the natural cycle and progestin-only contraceptives

G. Merki-Feld, D. Apter, L. Shulman, 2017, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Freeze-all versus fresh blastocyst transfer strategy during in vitro fertilisation in women with regular menstrual cycles: multicentre randomised controlled trial

A. Khatibi, J. Bogstad, A. Pinborg, 2020, BMJ.

Validation of spontaneous abortion diagnoses in the Danish National Registry of Patients

Timothy L Lash, Vera Ehrenstein, T. Lash, 2010, Clinical epidemiology.

Emergency contraceptive pills: medical and service delivery guidelines. 3rd ed.

Brache, J. Trussell, R. Reid, 2012 .

The influence on the pituitary-ovarian function, cervical mucus and vaginal cytology of a new progestational compound.

S. Skouby, 1976, Contraception.

EFFECT OF ORAL CONTRACEPTIVES

S. Skouby, 1976 .

Lipidomic profiles, lipid trajectories and clinical biomarkers in female elite endurance athletes

L. Ahonen, I. Mattila, C. Legido-Quigley, 2020, Scientific Reports.

Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes

L. Nilas, J. Faber, S. Skouby, 2015, Acta obstetricia et gynecologica Scandinavica.

Intrauterine devices in nulliparous women

S. Skouby, B. Jacobsen, K. R. Petersen, 1991, Advances in contraception : the official journal of the Society for the Advancement of Contraception.

European Society of Contraception Statement on Contraception in Obese Women

P. Crosignani, G. Merki-Feld, A. Cagnacci, 2015, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Effects of newer oral contraceptives on the inhibition of coagulation and fibrinolysis in relation to dosage and type of steroid.

J. Jespersen, S. Skouby, K. Petersen, 1990, American journal of obstetrics and gynecology.

Effects of monophasic low-dose oral contraceptives on fibrin formation and resolution in young women*†

J. Jespersen, S. Skouby, J. Sidelmann, 1993 .

Oral contraceptives and diabetes mellitus

J. Jespersen, S. Skouby, Petersen Kr, 1996 .

Ultrasound evaluation of ovarian activity under oral contraceptives.

H. Hoogland, S. Skouby, 1993, Contraception.

Laboratory and Clinical Assessment of a New Progestational Compound, Desogestrel

S. Skouby, 1982 .

Energy availability and the female athlete triad in elite endurance athletes

Å. Tornberg, A. Sjödin, J. Sundgot-Borgen, 2015, Scandinavian journal of medicine & science in sports.

The LEAF questionnaire: a screening tool for the identification of female athletes at risk for the female athlete triad

Christian Ritz, C. Ritz, Å. Tornberg, 2014, British Journal of Sports Medicine.

Impact of progestogens on hemostasis

S. Skouby, J. Sidelmann, 2018, Hormone molecular biology and clinical investigation.

Effect of Genomics on Venous Thrombosis: Relation to Sex Steroids

J. Jespersen, C. Kluft, E. Bladbjerg, 2006 .

Genital cancer and oral contraceptives. The good news!

S. Skouby, 2008, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Aortic Dimensions in Girls and Young Women with Turner Syndrome: A Magnetic Resonance Imaging Study

E. M. Pedersen, C. Gravholt, K. Mortensen, 2010, Pediatric Cardiology.

Maintenance of ovulation inhibition with a new progestogen-only pill containing drospirenone after scheduled 24-h delays in pill intake.

E. Colli, D. Heger-Mahn, S. Skouby, 2016, Contraception.

Diabetes prevention in postmenopausal women: lifestyle, metformin, and sex steroid intervention revisited.

S. Skouby, 2013, Menopause.

Glucose Metabolism After Menopause

S. Madsbad, S. Skouby, 2007 .

Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism

J. Trussell, L. Shulman, P. Darney, 2013, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

Statement on combined hormonal contraceptives containing third- or fourth-generation progestogens or cyproterone acetate, and the associated risk of thromboembolism

J. Trussell, L. Shulman, P. Darney, 2013, Journal of Family Planning and Reproductive Health Care.

Response to ovulation trigger is correlated to late follicular phase progesterone levels: A hypothesis explaining reduced reproductive outcomes caused by increased late follicular progesterone rise.

P. Humaidan, C. Andersen, S. Skouby, 2019, Human reproduction.

Safety after extended repeated use of ulipristal acetate for uterine fibroids

D. Barlow, B. Fauser, J. Donnez, 2017, PloS one.

Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.

A. Pines, F. al-Azzawi, D. Barlow, 2005, Maturitas.

Menstrual cycle and skin reactivity.

T. Agner, P. Damm, S. Skouby, 1991, Journal of the American Academy of Dermatology.

Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature

D. Apter, S. Weyers, N. Ács, 2020, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.

A low-dose start in hormone replacement therapy provides a beneficial bleeding profile and few side-effects: randomized comparison with a conventional-dose regimen

J. Heikkinen, L. Mattsson, S. Skouby, 2004, Climacteric : the journal of the International Menopause Society.

Semen Quality as a Predictor of Subsequent Morbidity: A Danish Cohort Study of 4,712 Men With Long-Term Follow-up

N. Jørgensen, J. Mehlsen, S. Skouby, 2017, American journal of epidemiology.

An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome.

E. Freeman, A. Rapkin, G. Constantine, 2011, Contraception.

Plasma factor VII-activating protease is increased by oral contraceptives and induces factor VII activation in-vivo.

F. Vitzthum, J. Jespersen, C. Kluft, 2011, Thrombosis research.

Hormonal Contraception in Women With IDDM: Influence on glycometabolic control and lipoprotein metabolism

S. Skouby, K. Petersen, A. Haaber, 1995, Diabetes Care.

13 Contraception for women with diabetes: An update

S. Skouby, L. Mølsted‐Pedersen, Petersen Kr, 1991 .